Subscribe
shutterstock_676034119_testing
Testing / Shutterstock.com
10 March 2022AmericasMuireann Bolger

FujiFilm sues Butterfly Network over ultrasound patents

A subsidiary of Tokyo-based FujiFilm has announced that it has filed a patent infringement lawsuit against ultrasound machine maker Butterfly Network.

Already registered?

Login to your account

To request a FREE 2-week trial subscription, please signup.
NOTE - this can take up to 48hrs to be approved.

Two Weeks Free Trial

For multi-user price options, or to check if your company has an existing subscription that we can add you to for FREE, please email Adrian Tapping at atapping@newtonmedia.co.uk


More on this story

Asia-Pacific
Fujifilm makes $800m acquisition
5 April 2018   Japan-based Fujifilm has revealed its plan to acquire two cell culture media companies for $800 million.
Asia-Pacific
Fujifilm signs influenza drug licensing deal
22 June 2016   Japan-based Fujifilm has signed a patent licensing agreement with a Chinese company centring on an ingredient used in its anti-influenza drug Avigan.


Editor's picks

Americas
UPC bans Meril Life Sciences from selling infringing heart valve
19 November 2024

Editor's picks

Americas
UPC bans Meril Life Sciences from selling infringing heart valve
19 November 2024

More on this story

Asia-Pacific
Fujifilm makes $800m acquisition
5 April 2018   Japan-based Fujifilm has revealed its plan to acquire two cell culture media companies for $800 million.
Asia-Pacific
Fujifilm signs influenza drug licensing deal
22 June 2016   Japan-based Fujifilm has signed a patent licensing agreement with a Chinese company centring on an ingredient used in its anti-influenza drug Avigan.

More on this story

Asia-Pacific
Fujifilm makes $800m acquisition
5 April 2018   Japan-based Fujifilm has revealed its plan to acquire two cell culture media companies for $800 million.
Asia-Pacific
Fujifilm signs influenza drug licensing deal
22 June 2016   Japan-based Fujifilm has signed a patent licensing agreement with a Chinese company centring on an ingredient used in its anti-influenza drug Avigan.

More features

Bayer gains exclusive licence for heart drug in Japan
EPO delivers key Novo Nordisk, GSK and Inhibrx rulings
McGuireWoods expands team with ex-Novo Nordisk GC
Paul, Weiss swoops for senior duo from Weil, Gotshal
UPC bans Meril Life Sciences from selling infringing heart valve
SCOTUS denies Alvogen unit's appeal to sell Bausch Xifaxan generic
Kathi Vidal to rejoin previous firm as partner following USPTO departure
GSK triumphs in EPO appeal, revoking Pfizer patent